admin

Portfolio company, Modern Democracy, ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in.Congratulations to Siobhan Donaghy and her team on delivering this great result for the recent GB elections. The below article is taken from: https://syncni.com/article/11966/derry-based-company-ensures-smooth-gb-elections-for-4-5m-voters-as-record-number-of-councils-adopt-digital-check-in Derry-based company Modern Democracy is forecasting further growth ahead of the […]

Neurovalens, a Belfast-headquartered specialist in non-invasive neuro-technology, has closed a £2.1m funding round with existing investors in preparation for a $40m-$50m Series B fundraising round. The firm has also received clearance from the US Food & Drug Administration (FDA) for its Modius Stress device. The below article is taken from: https://www.insidermedia.com/news/ireland/neurovalens-closes-2.1m-funding-round?utm_source=ireland_newsletter&utm_campaign=ireland_news_tracker&utm_medium=deals_article The company, whose medical

Congratulations to portfolio company, The Boatyard Distillery and, in particular, Joe McGirr and Declan McGurk, on this significant recognition. The Drinks International Report is seen as the global authority for the spirits world with the top 100 bars globally contributing to its publication. Boatyard climbed the rankings of both the top trending Vodka and Gin lists, and also made

Congratulations to portfolio company, CV6 Therapeutics, (NI) Ltd. and, in particular, Robert D. Ladner, Ph.D. on this significant commercial milestone. We look forward to following developments with interest as the company commences its first-in-human clinical trial. Article taken from: CV6 Therapeutics Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial (yahoo.com) CV6 Therapeutics

Congratulations to portfolio company, Neurovalens, and its CEO, Jason McKeown, on receiving clearance from the FDA on its Modius Sleep device for the treatment of chronic insomnia! A big milestone for the company – well done to the whole Neurovalens team! Article taken from: https://www.massdevice.com/fda-clears-insomnia-treating-device-neurovalens/ Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic

Belfast-based cyber security leader ANGOKA is to unveil a new solution which offers robust security in the face of emerging quantum threats about to confront our daily lives. Article taken from: https://angoka.io/angoka-to-reveal-next-generation-security-to-protect-last-mile-communications/ The new technology provides quantum-secure last mile key exchange (the security of data fundamentally relies on a secure exchange of cryptographic keys between